Inflammatory phenomena and itching in dermatoses amenable to corticosteroid therapy, including psoriasis (except for common plaque psoriasis) and atopic dermatitis, in adults and children aged 2 yEars and Nose and older.
active substance: mometasone furoate;
1 g of cream contains mometasone furoate 1 mg;
Elozon Excipients: isopropyl myristate, dimethicone, cetomacrogol, medium chain triglycerides, cetostearyl alcohol, glycerol monostearate, magnesium stearate, titanium dioxide (E 171), methylparaben (E 218), propylene glycol, citric acid, monohydric acid.
Elozon Dosage form
Main physical and chemical properties: homogeneous white cream without odor.
Corticosteroids for use in dermatology. Active corticosteroids (group III).
ATX code D07A C13.
Mometasone furoate is a synthetic glucocorticosteroid (GCS) for topical use with anti-inflammatory, antipruritic and anti-exudative effects.
Pharmacokinetic studies have shown that systemic absorption after topical application of mometasone furoate 0.1% is minimal; approximately 0.4% of the administered dose is eliminated from the body within 72 hours after application. It was almost impossible to establish the nature of the metabolites due to the small amount present in blood plasma and excreta.
Inflammatory phenomena and itching in dermatoses treated with corticosteroids, including psoriasis (except for common plaque psoriasis) and atopic dermatitis, in adults and children over 2 years of age.
Elozon® is contraindicated in rosacea, acne vulgaris, skin atrophy, perioral dermatitis, perianal and genital itching, diaper rash, bacterial (eg, impetigo, pyoderma), viral (eg, herpes simplex, shingles, herpes zoster and shingles). , contagious molluscum), parasitic and fungal (eg Candida or dermatophyte) infections, tuberculosis, syphilis or post-vaccination reactions. Elozon® should not be applied to wounds or ulcerated skin. The drug is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the drug.
Elozon® is contraindicated in patients with hypersensitivity to other glucocorticosteroids.
Interaction with other medicinal products and other forms of interaction